CClinicalTrials.gg
CompletedNCT00657670RECSUpdated Oct 9, 2009

Evaluation of Effectiveness of Correcting Refractive Error With Ready-made Spectacles

An interventional study of Ready-made spectacles and Spectacles in Myopia, Hyperopia and Astigmatism, sponsored by Johns Hopkins University. Completed at 2 sites in 2 countries. Open to participants aged 11 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-10-09.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
800
Allocation
Randomized
Ages
11 Years to 45 Years
Sex
All
01

Study summary

This research project will compare two methods of correcting refractive error (long or short-sightedness) with spectacle lenses. The primary outcome is the proportion of the population requiring spectacle correction who's needs are met through each scheme. Secondary outcomes are the cost effectiveness of these schemes and development of guidelines for identification of those amongst the population suitable for 'ready-made' spectacles.

There are two sites involved in this research. Those with uncorrected refractive error will be identified by their distance vision. Those who have impaired vision (at least 20/40) which improves with spectacles will be invited to participate in this research. Participants will be randomly allocated to one of two groups. The first group will receive spectacles with full correction in both eyes and the second group will receive spectacles from a limited inventory. The two schemes will be compared by how many people continue to use the spectacles, vision with the new spectacles, change in the level of visual functioning and quality of life after wearing new spectacles for one month. At the one month visit, if the spectacles provided are not useful, one new pair of custom spectacles will be dispensed.

Read the detailed description

In India, participants will be recruited from those attending Shroff's Charity Eye Hospital for refractive eye care. These individuals are screened for eye disease and visual acuity is measured as part of routine care. All with distance vision worse than 20/40 will have pinhole acuity taken to estimate benefit of refractive correction. Those who have refracted distance visual acuity better than 20/40 in the better eye and minimum spherical refractive error of ±1 dioptre will be eligible for the study. The clinical testing can be conducted on the same day and include habitual distance vision, refraction and refracted visual acuity.

In China, participants will be recruited from those identified by a School Screening Program in place in GuangZhou (Childsight). In this program, teachers measure visual acuity. Those who have 20/40 or worse distance vision will be invited to a parent information night. At this time, information will be provided about the study and those interested in participating will sign a record of informed assent with parental permission. The clinical testing will be conducted at a later visit by an optometrist attending the school. Study questionnaires will be administered and clinical testing of vision including habitual distance vision, refraction and refracted visual acuity.

The duration of the study will be up to 2 months and will require a total of three visits. After the initial visit, the dispensing visit will be arranged based on time to supply spectacles and the final visit planned for 1 month after receipt of spectacles.

This study will be masked. The persons interviewing the patients about quality of life and those testing vision on both visits will not know the intervention status of the subjects.

02

Conditions studied

  • Myopia
  • Hyperopia
  • Astigmatism

Keywords

  • refractive error
  • spectacles
  • ready made spectacles
  • vision
  • cost effectiveness
03

In context

Astigmatism

413 studies on the registry are indexed under Astigmatism; 55 are open to participants now.

This study's planned enrollment of 800 is above the median of 55 across 321 interventional studies indexed under Astigmatism.

Browse Astigmatism studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Presenting visual acuity of 20/40 or worse in the better eye, who have improvement to 20/40 or better following refraction
  • A minimum of 1 dioptre of spherical refractive error must be present
  • Aged 18-45 years of age at Shroffs Charity Eye Hospital
  • Junior High School Students approximate age 11-16 years of age at Zhongshan Ophthalmic Center

Exclusion criteria

Exclusion Criteria:

  • Those who do not correct to within 20/40 with spectacle correction.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
800 participants (estimated)

Study arms

  • Experimental
    1

    Ready-made spectacles

    Device: Ready-made spectacles

  • Active comparator
    2

    Spectacles

    Device: Spectacles

Interventions

  • DeviceReady-made spectacles

    Ready-made spectacles will be dispensed to correct refractive error. Ready-made spectacles are spectacles which are available from an existing inventory. This is different to prescription spectacles which are usually made to order. They have the same spherical power for the right and left eyes and do not include a correction for astigmatism. The limited inventory for this trial includes +1.00 to +4.00 in 0.50 steps, +5.00, +6.00 and +8.00, -1.00 to -6.00 in 0.50 steps, -7.00, -8.00, -9.00 and -10.00. The appropriate spectacles are selected based on the spherical equivalent refractive error. If there is a difference between the two eyes the lower correction is selected.

    Also known as: Off-the-shelf spectacles

  • DeviceSpectacles

    Spectacles will be prescribed to correct refractive error. These spectacles will be custom-prescribed based on the sphero-cylindrical refractive correction. The spectacles used in this arm will be custom made for each participant based on their refraction and can be made in a full range of spherical powers and astigmatic corrections for up to 2.00 dioptres of cylinder.

    Also known as: Prescription glasses

06

What researchers measure

Primary outcomes

  1. Wearer retention (% wearing at 1 month), vision (logMAR), visual function (0-100), quality of life (0-100)

    Time frame: a 1-month period of spectacle wear

Secondary outcomes

  1. Cost-effectiveness

    Time frame: 1-month of spectacle wear

  2. Willingness to pay

    Time frame: 1-month of spectacle wear

  3. Recommendations for those who will benefit from ready made spectacles

    Time frame: 1-month of spectacle wear

  4. Quantify the prismatic effects which has an impact of spectacle compliance, need for adaptation and satisfaction with spectacles

    Time frame: 1-month of spectacle wear

  5. Continued spectacle use 6-12 months after dispensing

    Time frame: 12 months

07

Study locations

2 sites
  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, China
  • Shroffs Charity Eye Hospital
    New Delhi, India
08

References and documents

Publications

  • Zeng Y, Keay L, He M, Mai J, Munoz B, Brady C, Friedman DS. A randomized, clinical trial evaluating ready-made and custom spectacles delivered via a school-based screening program in China. Ophthalmology. 2009 Oct;116(10):1839-45. doi: 10.1016/j.ophtha.2009.04.004. Epub 2009 Jul 9. PubMed 19592103 ↗
  • Angell B, Ali F, Gandhi M, Mathur U, Friedman DS, Jan S, Keay L. Ready-made and custom-made eyeglasses in India: a cost-effectiveness analysis of a randomised controlled trial. BMJ Open Ophthalmol. 2018 Feb 9;3(1):e000123. doi: 10.1136/bmjophth-2017-000123. eCollection 2018. PubMed 29657979 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 9, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00657670
Lead sponsor
Johns Hopkins University
Collaborators
National Health and Medical Research Council, Australia
First posted
Apr 14, 2008
Start date
Apr 2008
Primary completion
Nov 2008
Completion
Sep 2009
Last update
Oct 9, 2009

Study contacts

Lisa J Keay, PhD BOptom
principal investigator · Johns Hopkins University
Guofu Huang, MD
study director · Zhongshan Ophthalmic Center, Sun Yat-sen University
Monica Gandhi, MD
study director · Shroffs Charity Eye Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion